Trial NCT01522443

View at ClinicalTrials.gov 
Org. Study IDs: XL184-306

Last trial update was posted on 2018-05-23

MeSH Interventions

Mitoxantrone Prednisone

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Castration Resistant Prostate Cancer Pain Prostate Cancer

Stopping Reasons

Stopped after the outcome of cabozantinib Phase 3 CRPC study XL184-307.

Limitations And Caveats

Enrollment was stopped before planned study population size of 246 was reached (only 119 enrolled).

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID